PHESGO® is a subcutaneous combination of pertuzumab and trastuzumab for HER2-positive breast cancer, designed to reduce treatment time.
- You cannot add "Zytiga 500mg x 60Tabs (NAFDAC)" to the basket because the product is out of stock.
Product not listed ? Send us a DM !  > Dismiss
PHESGO® is a subcutaneous combination of pertuzumab and trastuzumab for HER2-positive breast cancer, designed to reduce treatment time.